Lenalidomide, dexamethasone and alemtuzumab or ofatumumab in high-risk chronic lymphocytic leukaemia: final results of the NCRI CLL210 trial

• Andrew R. Pettitt,
• Richard Jackson,
• Silvia Cicconi,
• Fotis Polydoros,
• Christina Yap,
• James Dodd,
• Matthew Bickerstaff,
• Michael Stackpoole,
• Umair T. Khan,
• Stacey Carruthers,
• Melanie Oates,
• Ke Lin,
• Sarah E. Coupland,
• Geetha Menon,
• Nagesh Kalakonda,
• Helen McCarthy,
• Adrian Bloor,
• Anna Schuh,
• Andrew Duncombe,
• Claire Dearden,
• Christopher Fegan,
• Ben Kennedy,
• Renata Walewska,
• Scott Marshall,
• Christopher P. Fox,
• Peter Hillmen

Affiliations

Andrew R. Pettitt

University of Liverpool and Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK;

Richard Jackson

University of Liverpool, Liverpool, UK;

Silvia Cicconi

University of Liverpool, Liverpool, UK;

Fotis Polydoros

University of Liverpool, Liverpool, UK;

Christina Yap

University of Birmingham, Birmingham, UK;

James Dodd

University of Liverpool, Liverpool, UK;

Matthew Bickerstaff

University of Liverpool, Liverpool, UK;

Michael Stackpoole

University of Liverpool, Liverpool, UK;

Umair T. Khan

University of Liverpool and Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK;

Stacey Carruthers

University of Liverpool, Liverpool, UK;

Melanie Oates

University of Liverpool, Liverpool, UK;

Ke Lin

Univ of Liverpool and Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK;

Sarah E. Coupland

Univ of Liverpool and Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK;

Geetha Menon

Univ of Liverpool and Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK;

Nagesh Kalakonda

Univ of Liverpool and Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK;

Helen McCarthy

The Royal Bournemouth Hospital, Bournemouth, UK;

Adrian Bloor

The Christie NHS Foundation Trust, Manchester, UK;

Anna Schuh

Churchill Hospital, Oxford, UK;

Andrew Duncombe

Southampton General Hospital, Southampton, UK;

Claire Dearden

Royal Marsden NHS Foundation Trust, Sutton, UK;

Christopher Fegan

University Hospital of Wales, Cardiff, UK;

Ben Kennedy

Leicester Royal Infirmary, Leicester, UK;

Renata Walewska

The Royal Bournemouth Hospital, Bournemouth, UK;

Scott Marshall

City Hospitals Sunderland NHS Trust, Sunderland, UK;

Christopher P. Fox

Nottingham University Hospitals NHS Trust, Nottingham, UK;

Peter Hillmen

University of Leeds, Leeds, UK